- Tumors1000+
- Cancer1000+
- Pathologic Processes1000+
- Pathology1000+
- Nervous System Diseases1000+
Any
<10 miles
<30 miles
<50 miles
<70 miles
Filter Results
Condition
- Tumors1000+
- Cancer1000+
- Pathologic Processes1000+
- Pathology1000+
- Nervous System Diseases1000+
Where are you looking?
How far are you willing to travel?Any
How old are you?
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
- HER2 negative
- ER positive
- HER2 positive
- PD-L1 positive
- PR positive
- KRAS positive
- EGFR positive
- PR negative
- ER negative
- p16 positive
- PD-L1 negative
- BRAF positive
- EGFR negative
- ALK negative
- BRCA1 positive
- BRCA2 positive
- CD20 positive
- HLA-A positive
- IDH positive
- MET positive
- CD19 positive
- ALK positive
- IDH negative
- ROS1 negative
- p16 negative
- HLA positive
- HPV positive
- HR positive
- NRAS positive
- ROS1 positive
- PALB2 positive
- TP53 positive
- MYC positive
- MSI-H positive
- BRAF negative
- HPV negative
- MET negative
- PIK3CA positive
- dMMR positive
- HLA negative
- RET positive
- MGMT negative
- ANA positive
- BRCA positive
- HLA-A negative
- KIT positive
- NF1 positive
- RAS positive
- RB1 negative
- RB1 positive
- ATM positive
- HRAS positive
- KRAS negative
- NTRK positive
- ARID1A positive
- BCL2 positive
- CFTR positive
- MGMT positive
- MLH1 positive
- MMR positive
- MSH2 positive
- MSH6 positive
- anti-dsDNA positive
- BCR-ABL1 positive
- CCND1 positive
- CHEK2 positive
- FLT3 positive
- PMS2 positive
- PTEN positive
- RET negative
- BCL6 positive
- BRIP1 positive
- CD30 positive
- PD-1 positive
- RAD51 positive
- FANCA positive
- FGFR2 positive
- HBsAg positive
- HbSS positive
- MMR negative
- NRAS negative
- PD-1 negative
- TP53 negative
- anti-Sm positive
- BRCA negative
- CD123 positive
- CD22 positive
- DMD positive
- FMR1 positive
- HBV DNA negative
- HBsAg negative
- HPV16 positive
- HR negative
- MSI-H negative
- MTAP positive
- NTRK negative
- NTRK1 positive
- RAS negative
- RF positive
- SMARCA4 positive
- STK11 positive
- TROP2 positive
- ctDNA positive
- dMMR negative
- ABCA4 positive
- APC positive
- APOL1 positive
- AR positive
- BARD1 positive
- BRCA1 negative
- BRCA2 negative
- CD3 positive
- DLL3 positive
- EPCAM positive
- FGFR positive
- FGFR3 positive
- GPC3 positive
- GRN positive
- HBV DNA positive
- KMT2A positive
- Ki-67 positive
- MECP2 positive
- MSI negative
- MSI positive
- MSS negative
- MSS positive
- NF2 positive
- NPM1 positive
- PDGFRA positive
- Philadelphia chromosome positive
- SMN1 positive
- TROP2 negative
- ZnT8 positive
- p53 positive
- t(11;14) positive
- t(14;16) positive
- t(4;14) positive
- AChR positive
- AKT1 positive
- ARAF positive
- ASXL1 positive
- BAP1 positive
- C5 positive
- CD19 negative
- CD30 negative
- CD33 positive
- CD4 positive
- CD5 positive
- CD8 positive
- CDK12 positive
- CDK4 positive
- CLDN18.2 positive
- CTNNB1 positive
- DMPK positive
- DNMT3A positive
- EBV positive
- Ex19del positive
- HBcAb negative
- HbSβ0-thalassemia positive
- IA-2 positive
- IAA positive
- L858R positive
- MuSK positive
- PIK3CA negative
- PTEN negative
- PTPN11 positive
- Ph positive
- PiZZ positive
- RAD54L positive
- RAF positive
- RUNX1 positive
- SMARCB1 positive
- SMN2 positive
- T790M positive
- TERT positive
- TMB positive
- TSC1 positive
- TSC2 positive
- anti-AChR positive
- anti-Ro autoantibodies positive
- del(17p) positive
- dsDNA positive
- t(14;20) positive
- AKT negative
- APOE positive
- APP positive
- ATR positive
- Anti-PLA2R positive
- ApoE negative
- BCR-ABL positive
- BCR::ABL1 positive
- CA-125 positive
- CCNE1 positive
- CD10 positive
- CD4 count positive
- CD70 positive
- CDH1 positive
- CHEK1 positive
- COL7A1 positive
- CRAF positive
- Gleason Score 10
- Gleason Score 7
- Gleason Score 8
- Gleason Score 9
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Stage IV
- Stage III
- Stage II
- Stage I
- 1927nm Fractional Thulium Laser Treatment
- Adjuvant Chemotherapy without Concurrent Biologic/Targeted Therapy
- Adjuvant Therapy (except reconstruction)
- Alopecia from Prior Anti-Cancer Therapy
- Alopecia from Prior Treatment
- Anemia from Prior Anti-Cancer Therapy
- Anti-Seizure Medications (up to 2 types)
- Antibody-Based Therapy
- Antifibrotic Medications (Nintedanib, Pirfenidone)
- Any Prior Treatment
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
8211 trials
1
2
3
…50